Foster & Motley Inc Quest Diagnostics Inc Transaction History

Foster & Motley Inc

  • $1.86 Billion
  • Q3 2025

A detailed history of Foster & Motley Inc transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Foster & Motley Inc holds 24,562 shares of DGX stock, worth $3.37 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
24,562
Previous 28,785 14.67%
Holding current value
$3.37 Million
Previous $5.17 Million 9.48%
% of portfolio
0.25%
Previous 0.3%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025
SELL
N/A
-4,223 Reduced 14.67%
24,562 $4.68 Million
Q2 2025

Jul 29, 2025
SELL
N/A
-1,844 Reduced 6.02%
28,785 $5.17 Million
Q1 2025

May 08, 2025
SELL
N/A
-1,735 Reduced 5.36%
30,629 $5.18 Million
Q4 2024

Jan 23, 2025
SELL
N/A
-1,352 Reduced 4.01%
32,364 $4.88 Million
Q3 2024

Oct 30, 2024
SELL
$137.09 - $137.09 $323,806 - $323,806
-2,362 Reduced 6.55%
33,716 $5.23 Million
Q2 2024

Aug 02, 2024
SELL
$125.91 - $144.34 $119,866 - $137,411
-952 Reduced 2.57%
36,078 $4.94 Million
Q1 2024

Apr 18, 2024
SELL
$123.78 - $142.11 $388,669 - $446,225
-3,140 Reduced 7.82%
37,030 $4.93 Million
Q4 2023

Feb 01, 2024
SELL
$120.62 - $141.12 $63,807 - $74,652
-529 Reduced 1.3%
40,170 $5.54 Million
Q3 2023

Oct 24, 2023
BUY
$121.86 - $144.92 $109,430 - $130,138
898 Added 2.26%
40,699 $4.96 Million
Q2 2023

Aug 08, 2023
BUY
$130.56 - $146.84 $125,990 - $141,700
965 Added 2.48%
39,801 $5.59 Million
Q1 2023

May 09, 2023
BUY
$131.53 - $155.76 $928,864 - $1.1 Million
7,062 Added 22.23%
38,836 $5.5 Million
Q4 2022

Feb 09, 2023
BUY
$123.31 - $157.26 $418,637 - $533,897
3,395 Added 11.96%
31,774 $4.97 Million
Q3 2022

Nov 04, 2022
SELL
$121.77 - $141.1 $38,114 - $44,164
-313 Reduced 1.09%
28,379 $3.48 Million
Q2 2022

Aug 09, 2022
SELL
$127.07 - $145.39 $93,015 - $106,425
-732 Reduced 2.49%
28,692 $3.82 Million
Q1 2022

Apr 28, 2022
SELL
$129.09 - $164.35 $98,366 - $125,234
-762 Reduced 2.52%
29,424 $4.03 Million
Q4 2021

Jan 25, 2022
BUY
$140.36 - $173.01 $139,517 - $171,971
994 Added 3.41%
30,186 $5.22 Million
Q3 2021

Oct 29, 2021
BUY
$132.95 - $158.0 $42,278 - $50,244
318 Added 1.1%
29,192 $4.24 Million
Q2 2021

Jul 20, 2021
BUY
$126.66 - $141.48 $93,475 - $104,412
738 Added 2.62%
28,874 $3.81 Million
Q1 2021

Apr 26, 2021
BUY
$114.63 - $133.34 $389,856 - $453,489
3,401 Added 13.75%
28,136 $3.61 Million
Q4 2020

Feb 01, 2021
BUY
$112.7 - $128.05 $637,205 - $723,994
5,654 Added 29.63%
24,735 $2.95 Million
Q3 2020

Oct 19, 2020
BUY
$107.05 - $130.01 $103,089 - $125,199
963 Added 5.32%
19,081 $2.19 Million
Q2 2020

Jul 20, 2020
BUY
$73.34 - $122.61 $351,298 - $587,301
4,790 Added 35.94%
18,118 $2.07 Million
Q1 2020

Apr 21, 2020
BUY
$75.14 - $115.68 $640,042 - $985,362
8,518 Added 177.09%
13,328 $1.07 Million
Q4 2019

Feb 05, 2020
SELL
$100.29 - $107.99 $5,415 - $5,831
-54 Reduced 1.11%
4,810 $514,000
Q3 2019

Oct 24, 2019
BUY
$97.85 - $107.42 $3,718 - $4,081
38 Added 0.79%
4,864 $521,000
Q2 2019

Jul 17, 2019
SELL
$85.18 - $101.94 $23,765 - $28,441
-279 Reduced 5.47%
4,826 $491,000
Q4 2018

Jan 30, 2019
SELL
$79.75 - $108.38 $72,971 - $99,167
-915 Reduced 15.2%
5,105 $425,000
Q3 2018

Oct 31, 2018
SELL
$105.42 - $114.99 $41,008 - $44,731
-389 Reduced 6.07%
6,020 $650,000
Q2 2018

Jul 24, 2018
SELL
$97.35 - $113.14 $3,115 - $3,620
-32 Reduced 0.5%
6,409 $705,000
Q1 2018

May 14, 2018
SELL
$96.42 - $107.88 $28,154 - $31,500
-292 Reduced 4.34%
6,441 $646,000
Q4 2017

Jan 22, 2018
BUY
$90.86 - $100.24 $84,045 - $92,722
925 Added 15.93%
6,733 $663,000
Q3 2017

Oct 19, 2017
BUY
$91.96 - $108.35 $534,103 - $629,296
5,808
5,808 $544,000

Others Institutions Holding DGX

# of Institutions
1,109
Shares Held
107M
Call Options Held
469K
Put Options Held
601K
View Full List

About QUEST DIAGNOSTICS INC

DGX Quotes by TradingView
  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Foster & Motley Inc Portfolio

Follow Foster & Motley Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email